Jubilant Pharmova informs about outcome of board meeting

19 Jul 2024 Evaluate

Pursuant to the provisions of Regulation 33 read with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the ‘Listing Regulations’) (as amended), Jubilant Pharmova has informed that the Board of Directors of the Company has, at its meeting held today on Friday, July 19, 2024 at 12:15 pm that concluded at 02:00 pm, approved the following: Un-audited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30, 2024; Grant of 45,448 Stock Options to the eligible employees under the Jubilant Pharmova Employees Stock Option Plan 2018. Pursuant to applicable provisions of the Listing Regulations, it has enclosed the following: The Unaudited Financial Results (Standalone and Consolidated) for the quarter ended June 30, 2024; Limited Review Reports on the Unaudited Financial Results (Standalone and Consolidated) for the said quarter; The details pursuant to SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 Circular dated July 13, 2023 with respect to Stock Options granted to the eligible employees is annexed as Annexure -1. The above-mentioned documents will be simultaneously posted on the Company's website at www.jubilantpharmova.com.

The above information is a part of company’s filings submitted to BSE.

Jubilant Pharmova Share Price

1076.50 7.30 (0.68%)
05-Dec-2025 15:04 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1805.15
Dr. Reddys Lab 1275.50
Cipla 1521.80
Zydus Lifesciences 931.80
Lupin 2100.85
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×